However, elevated ANXA6 levels have been found in the progression of pancreatic cancer [27–29], female thyroid cancer [30], squamous cervical cancer [31], ovarian cancer [32], esophageal adenocarcinoma [33], and melanoma [34]. This evidence concerns the gene ANXA6 and ovarian cancer.